Gene therapy has made remarkable strides in recent years, with 20 approved indications in the United States and a record number of approvals in 2023. Investigational trials are rapidly increasing across various diseases, including hemophilia B, sickle cell disease, and Duchenne muscular dystrophy.
Recent advancements in the field of cancer immunotherapy have unveiled an exciting discovery that involves the molecule MR1 and vitamin B6. Researchers at Monash University Biomedicine Discovery Institute, in collaboration with the University of Melbourne, have found that MR1 can bind to a form of
Halitosis, commonly known as bad breath, is a condition that can significantly impact social interactions and quality of life, particularly in children. This distressing issue is often exacerbated by mouth breathing, a habit in many youngsters that compromises the natural antibacterial properties
In a bold move to tackle one of the most formidable cancers, Anocca AB has announced the submission of a Clinical Trial Application (CTA) to the European Medicines Agency (EMA) for their innovative VIDAR-1 Phase I/II multi-asset trial, targeting advanced pancreatic cancer. The pioneering trial, set
The launch of an advanced cell restoration treatment in Thailand marks a significant milestone in the Thai-Japan partnership. NihonChojyu Clinic, established by Dr. Masatoshi Egoshi, is at the forefront of this healthcare innovation, emphasizing the restoration of health and beauty from the
Recent research has uncovered a startling discovery: certain rare genetic mutations in the breast cells of healthy women may be early indicators of breast cancer development. This groundbreaking study, conducted by researchers from the University of British Columbia (UBC), BC Cancer, Harvard